Clinical trial NCT05039697: Normobaric Hyperoxia Combined With Endovascular Therapy in Patients With Stroke Within 6 Hours of Onset：Longterm Outcome
Official title: Normobaric Hyperoxia Combined With Endovascular Therapy in Patients With Stroke Within 6 Hours of Onset：Longterm Outcome Analysis
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Stroke, Acute
Hypoxia-Ischemia, Brain
ENDOVASCULAR TREATMENT
Lead sponsor: Capital Medical University
Sponsor class: OTHER
First posted: 2021-09-09
Enrollment: 282
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The overall incidence of good outcome for AIS following endovascular treatment is only proximately 50%. Whether NBO was safe and effective to improve acute ischemic stroke prognosis is still unclear. The investigators' hypothesis is thatNBO is a safe and effective strategy to improve longterm outcome in AIS patients undergoing endovascular treatment.

Detailed description: NBO therapy is to deliver high flow oxygen (10L/min) through an oxygen storage mask. This treatment should be started in the emergency room immediately after the patient is randomized into the group, and oxygen should be continued for 4 hours.

In previous clinical studies of NBO, patients who have not receive revascularization often choose NBO for 8 hours, and studies have concluded that oxygen inhalation for more than 10 hours may bring about the risk of oxygen poisoning. However, a too short treatment time may not bring benefits. Secondly, ideally, we want to ensure that stroke patients receive NBO treatment before achieving reperfusion to protect the ischemic brain tissue, and add 1-2 hours after reperfusion. In the clinical environment after the patient arrives in the emergency department, it takes 2-3 hours to complete the revascularization process. Therefore, we believe that 4 hours of oxygen inhalation is reasonable. And our single-center study also supports that NBO treatment for 4 hours is beneficial.

The specific content is as follows: In the emergency room, patients who are assessed for suspected large blood vessels of acute anterior circulation will be randomized after signing the informed consent. If the subject is randomly divided into NBO+ET group, by putting the patient on Oxygen mask, and then immediately give oxygen (10L/min). NBO treatment is no later than half an hour after randomization. Oxygen comes from the hospital's oxygen center and is transported through wall pipes (oxygen concentration: 100%). The oxygen mask and the wall oxygen are connected by a 1.5 meter long oxygen pipe. When the patient is transferred to the operating room, we provide oxygen through a portable oxygen cylinder (capacity: 4L). In addition, in the operating room and intensive care unit, patients continue to be given wall oxygen therapy until the oxygen inhalation lasts for 4 hours. The arterial blood gas was drawn after 4 hours of oxygen inhalation. The control group directly inhales room air through the patient's nasal cavity without using any equipment. At the same time, patients in the control group were also drawn blood gas analysis at corresponding time points (approximately 4 hours after randomization).

Eligibility criteria: Inclusion Criteria:

* Age ≥ 18 years old.
* The clinical symptoms and signs are consistent with acute anterior circulation large vessel occlusion;
* NIHSS score ≥ 10 points;
* (Level of consciousness) NIHSS score 0 or 1;
* The time from onset to randomization is within 6 hours of onset;
* The mRS score before stroke is 0-1;
* The patient has good compliance and can complete the operation with local anesthesia;
* The patient can cooperate with this study and follow-up in the future
* Patient and family members sign informed consent。-

Exclusion Criteria:

* Rapid neurological function improvement, NIHSS score less than 10 points, or evidence of vessel recanalization prior to randomization;
* Seizures at stroke onset;
* Intracranial hemorrhage;
* Symptoms suggestive of subarachnoid hemorrhage, even if CT scan was normal;
* Platelet count of less than 100,000 per cubic millimeter;
* Severe hepatic or renal dysfunction;
* Active and chronic obstructive pulmonary disease or acute respiratory distress syndrome;
* \>3 L/min oxygen required to maintain peripheral arterial oxygen saturation (SaO2) 95% as per current stroke management guidelines;
* Medically unstable;
* Life expectancy\<90 days;
* Evidence of intracranial tumor;

Primary outcomes:
measure: Modified Rankin Scale
timeFrame: 1 year ± 30 days after randomization
Secondary outcomes:
measure: EuroQol- 5 Dimension (EQ-5D)
timeFrame: 1 year ± 30 days after randomization
measure: The proportion of good prognosis
timeFrame: 1 year ± 30 days after randomization
measure: Functional independence
timeFrame: 1 year ± 30 days after randomization
measure: The Proportion of mRS 0-3
timeFrame: 1 year ± 30 days after randomization
measure: Barthel Index (BI)
timeFrame: 1 year ± 30 days after randomization
measure: All-cause mortality
timeFrame: 1 year ± 30 days after randomization
measure: New major vascular events
timeFrame: 1 year ± 30 days after randomization
measure: kaplan-meier curve
timeFrame: 1 year ± 30 days after randomization
Other outcomes:
Locations:
city: Beijing
country: China
facility: Baojun Hou
state: Beijing
Study officials:
affiliation: Xuan Wu Hospital#Capital Medical University
name: Xunming Ji, MD
role: STUDY_CHAIR
References: